BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 23762309)

  • 1. The role of the e3 ligase cbl-B in murine dendritic cells.
    Wallner S; Lutz-Nicoladoni C; Tripp CH; Gastl G; Baier G; Penninger JM; Stoitzner P; Wolf D
    PLoS One; 2013; 8(6):e65178. PubMed ID: 23762309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
    Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
    Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model.
    Hinterleitner R; Gruber T; Pfeifhofer-Obermair C; Lutz-Nicoladoni C; Tzankov A; Schuster M; Penninger JM; Loibner H; Lametschwandtner G; Wolf D; Baier G
    PLoS One; 2012; 7(9):e44295. PubMed ID: 22962608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
    BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.
    Loeser S; Loser K; Bijker MS; Rangachari M; van der Burg SH; Wada T; Beissert S; Melief CJ; Penninger JM
    J Exp Med; 2007 Apr; 204(4):879-91. PubMed ID: 17403934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin Ligases CBL and CBL-B Maintain the Homeostasis and Immune Quiescence of Dendritic Cells.
    Tong H; Li X; Zhang J; Gong L; Sun W; Calderon V; Zhang X; Li Y; Gadzinski A; Langdon WY; Reizis B; Zou Y; Gu H
    Front Immunol; 2021; 12():757231. PubMed ID: 34630435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal preparation (HemoHIM) enhanced functional maturation of bone marrow-derived dendritic cells mediated toll-like receptor 4.
    Lee SJ; Kim JJ; Kang KY; Hwang YH; Jeong GY; Jo SK; Jung U; Park HR; Yee ST
    BMC Complement Altern Med; 2016 Feb; 16():67. PubMed ID: 26891999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of culture medium on maturation of bone marrow-derived murine dendritic cells via the aryl hydrocarbon receptor.
    Ilchmann A; Krause M; Heilmann M; Burgdorf S; Vieths S; Toda M
    Mol Immunol; 2012 May; 51(1):42-50. PubMed ID: 22377453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
    Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
    J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells.
    Park SN; Noh KT; Jeong YI; Jung ID; Kang HK; Cha GS; Lee SJ; Seo JK; Kang DH; Hwang TH; Lee EK; Kwon B; Park YM
    Exp Mol Med; 2013 Feb; 45(2):e8. PubMed ID: 23392255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
    Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
    J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
    Hoyne GF; Flening E; Yabas M; Teh C; Altin JA; Randall K; Thien CB; Langdon WY; Goodnow CC
    J Immunol; 2011 Feb; 186(4):2024-32. PubMed ID: 21248249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
    Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G
    Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.
    Cruz LJ; Rosalia RA; Kleinovink JW; Rueda F; Löwik CW; Ossendorp F
    J Control Release; 2014 Oct; 192():209-18. PubMed ID: 25068703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stimulation by Lycium bararum polysaccharides of the maturation of dendritic cells in murine bone marrow].
    Zhu J; Zhao LH; Chen Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 35(6):648-52. PubMed ID: 17177338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cbl-b regulates airway mucosal tolerance to aeroallergen.
    Oh SY; Park JU; Zheng T; Kim YK; Wu F; Cho SH; Barber D; Penninger J; Zhu Z
    Clin Exp Allergy; 2011 Mar; 41(3):434-42. PubMed ID: 20738317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency.
    Teh CE; Daley SR; Enders A; Goodnow CC
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14709-14. PubMed ID: 20668237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.